|
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) Clinical research trials and Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD). Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) clinical trial. Participants oftentimes recieve the finest healthcare available for their Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "R" Clinical Trials Conditions > Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)  Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
For Condition: Macular Degeneration
Status: Recruiting
Sponsor(s): Vascular Sciences Corporation ,
Synopsis: AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 50 Years/85 Years
Genders: Both
Protocol Entry Criteria: - Age 50-85 - Diagnosis of Dry AMD - BCVA between 20/32 and 20/125 in at least one eye - Numerous large plaques (soft drusen) - No history of HIV, Hepatitis B or C - Elevation of certain blood factors, such as total cholesterol, fibrinogen, and IgA
Total Enrollment: 180
Location and Contact Information:
Overall Study Official:
IrvingSiegel, Study Director, Vascular Sciences Corporation
W. Bradley Kates, MD *Recruiting*
Oakville, Ontario, L6H 3P1
Canada
Recruiting Susan Achal 416 / 970-7123
Carolina Eye Associates *Recruiting*
Southern Pines, North Carolina, 28387
United States
Recruiting Avie Banks 910-295-2100
UIC Eye Center *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting Jeff Parker 312-996-4747
Retina Health Care *Recruiting*
Ft. Myers, Florida, 33901
United States
Recruiting Chris Elkins 239-337-3337
Macula Care *Recruiting*
New York City, New York, 10021
United States
Recruiting Wanda Boyd 212-439-9600
Retina Vitreous Associates *Recruiting*
Beverly Hills, California, 90211
United States
Recruiting Joe Martinez 310-854-6201
Associated Retinal Consultants *Recruiting*
Bala Cynwyd, Pennsylvania, 19004
United States
Recruiting Tom Walker 610-660-0446
Additional Information:
Study ID Numbers: AMD-02-99;
Study Start Date: August 1999
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00078221
Other Macular Degeneration Studies:
1. Randomized Trials of Vitamin Supplements and Eye Disease
2. Open-Label Posterior Juxtacleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients with AMD
3. Effect of DHA Supplements on Macular Function in Patients with Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
4. Submacular Surgery Trials (SST)
5. An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD.
Related Studies:
Other Macular Degeneration Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
|
|
|
|
|
|
|
|
